Loading…
Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit
1 Rilmenidine has recently been introduced as a new centrally‐acting antihypertensive agent. We examined its cardiovascular effects after intracerebral injection to anaesthetized rabbits. Cumulative doses of rilmenidine injected intracisternally (1 to 300 μg kg−1) led to dose‐dependent decreases in...
Saved in:
Published in: | British journal of pharmacology 1990-07, Vol.100 (3), p.600-604 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5393-7d7854a2e2a04423daed09a3f7ef5baa4a4a2d6c1c73a02f0c86c5c5133e6f0e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c5393-7d7854a2e2a04423daed09a3f7ef5baa4a4a2d6c1c73a02f0c86c5c5133e6f0e3 |
container_end_page | 604 |
container_issue | 3 |
container_start_page | 600 |
container_title | British journal of pharmacology |
container_volume | 100 |
creator | Feldman, J. Tibiriça, E. Bricca, G. Dontenwill, M. Belcourt, A. Bousquet, P. |
description | 1
Rilmenidine has recently been introduced as a new centrally‐acting antihypertensive agent. We examined its cardiovascular effects after intracerebral injection to anaesthetized rabbits. Cumulative doses of rilmenidine injected intracisternally (1 to 300 μg kg−1) led to dose‐dependent decreases in arterial blood pressure and heart rate. The effective doses of rilmenidine were lower when injected centrally than when injected intravenously.
2
Pretreatment with the same dose of yohimbine or idazoxan shifted the rilmenidine dose‐response curves for its hypotensive and bradycardic effects to the right. Idazoxan, which has an imidazoline structure, proved to be a more active antagonist than yohimbine of rilmenidine centrally‐mediated cardiovascular effects.
3
The dose‐response curve for the central hypotensive effect of rilmenidine was also shifted to the right after pretreatment with a bovine brain extract. This extract contains the endogenous ligand of the imidazoline‐preferring receptors which is not a catecholamine.
4
Rilmenidine, like clonidine, proved to be active when micro‐injected into the rabbit nucleus reticularis lateralis region.
5
In conclusion, rilmenidine exhibited in the rabbit a central hypotensive effect which originated in the same area as where clonidine acts. Specific imidazoline‐preferring receptors appear to be involved in this hypotensive effect. |
doi_str_mv | 10.1111/j.1476-5381.1990.tb15853.x |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1917804</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15795369</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5393-7d7854a2e2a04423daed09a3f7ef5baa4a4a2d6c1c73a02f0c86c5c5133e6f0e3</originalsourceid><addsrcrecordid>eNqVkcGP1CAYxYnRrOPqn2DSmLi3ViilFA9G3ayuySZ60DOh9MNhQssIne6Of710phn1tFk4QPJ-7_GRh9ArgguS1ptNQSpe54w2pCBC4GJsCWsYLe4eodVJeoxWGGOeE9I0T9GzGDcYJ5GzM3RWUoHrplyh8WqyHQwaMuNDNq4hs8Pk3QQ9DGPmTWZ726nf3tkBsgAatqMPMUEHVicoKJet91s_whDtBBkYA_pgDdalFNvN1sUQVNva8Tl6YpSL8GI5z9GPT1ffL6_zm6-fv1x-uMk1o4LmvOMNq1QJpcJVVdJOQYeFooaDYa1SVdplV2uiOVW4NFg3tWaaEUqhNhjoOXp3zN3u2h66ZVq5DbZXYS-9svJ_ZbBr-dNPkgjCG1ylgIslIPhfO4ij7G3U4JwawO-i5EIwXlf8XpAwLhitRQLfHkEdfIwBzGkaguVcrtzIuUE5NyjncuVSrrxL5pf__udkXdpM-utFV1ErZ4IatI1_XxCUY07rxL0_crfWwf4BE8iP364PV_oHFa_Fyg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15795369</pqid></control><display><type>article</type><title>Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit</title><source>PubMed Central</source><creator>Feldman, J. ; Tibiriça, E. ; Bricca, G. ; Dontenwill, M. ; Belcourt, A. ; Bousquet, P.</creator><creatorcontrib>Feldman, J. ; Tibiriça, E. ; Bricca, G. ; Dontenwill, M. ; Belcourt, A. ; Bousquet, P.</creatorcontrib><description>1
Rilmenidine has recently been introduced as a new centrally‐acting antihypertensive agent. We examined its cardiovascular effects after intracerebral injection to anaesthetized rabbits. Cumulative doses of rilmenidine injected intracisternally (1 to 300 μg kg−1) led to dose‐dependent decreases in arterial blood pressure and heart rate. The effective doses of rilmenidine were lower when injected centrally than when injected intravenously.
2
Pretreatment with the same dose of yohimbine or idazoxan shifted the rilmenidine dose‐response curves for its hypotensive and bradycardic effects to the right. Idazoxan, which has an imidazoline structure, proved to be a more active antagonist than yohimbine of rilmenidine centrally‐mediated cardiovascular effects.
3
The dose‐response curve for the central hypotensive effect of rilmenidine was also shifted to the right after pretreatment with a bovine brain extract. This extract contains the endogenous ligand of the imidazoline‐preferring receptors which is not a catecholamine.
4
Rilmenidine, like clonidine, proved to be active when micro‐injected into the rabbit nucleus reticularis lateralis region.
5
In conclusion, rilmenidine exhibited in the rabbit a central hypotensive effect which originated in the same area as where clonidine acts. Specific imidazoline‐preferring receptors appear to be involved in this hypotensive effect.</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1111/j.1476-5381.1990.tb15853.x</identifier><identifier>PMID: 2390682</identifier><identifier>CODEN: BJPCBM</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Animals ; Antihypertensive agents ; Antihypertensive Agents - administration & dosage ; Antihypertensive Agents - pharmacology ; Biological and medical sciences ; Blood Pressure - drug effects ; Brain - physiology ; Cardiovascular system ; Cisterna Magna ; Dioxanes - pharmacology ; Heart Rate - drug effects ; Hemodynamics - drug effects ; Idazoxan ; Imidazoline Receptors ; Injections ; Injections, Intraventricular ; Male ; Medical sciences ; Oxazoles - administration & dosage ; Oxazoles - pharmacology ; Pharmacology. Drug treatments ; Rabbits ; Receptors, Drug - physiology ; Rilmenidine ; Tissue Extracts - analysis ; Yohimbine - pharmacology</subject><ispartof>British journal of pharmacology, 1990-07, Vol.100 (3), p.600-604</ispartof><rights>1990 British Pharmacological Society</rights><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5393-7d7854a2e2a04423daed09a3f7ef5baa4a4a2d6c1c73a02f0c86c5c5133e6f0e3</citedby><cites>FETCH-LOGICAL-c5393-7d7854a2e2a04423daed09a3f7ef5baa4a4a2d6c1c73a02f0c86c5c5133e6f0e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1917804/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1917804/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19370736$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2390682$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Feldman, J.</creatorcontrib><creatorcontrib>Tibiriça, E.</creatorcontrib><creatorcontrib>Bricca, G.</creatorcontrib><creatorcontrib>Dontenwill, M.</creatorcontrib><creatorcontrib>Belcourt, A.</creatorcontrib><creatorcontrib>Bousquet, P.</creatorcontrib><title>Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>1
Rilmenidine has recently been introduced as a new centrally‐acting antihypertensive agent. We examined its cardiovascular effects after intracerebral injection to anaesthetized rabbits. Cumulative doses of rilmenidine injected intracisternally (1 to 300 μg kg−1) led to dose‐dependent decreases in arterial blood pressure and heart rate. The effective doses of rilmenidine were lower when injected centrally than when injected intravenously.
2
Pretreatment with the same dose of yohimbine or idazoxan shifted the rilmenidine dose‐response curves for its hypotensive and bradycardic effects to the right. Idazoxan, which has an imidazoline structure, proved to be a more active antagonist than yohimbine of rilmenidine centrally‐mediated cardiovascular effects.
3
The dose‐response curve for the central hypotensive effect of rilmenidine was also shifted to the right after pretreatment with a bovine brain extract. This extract contains the endogenous ligand of the imidazoline‐preferring receptors which is not a catecholamine.
4
Rilmenidine, like clonidine, proved to be active when micro‐injected into the rabbit nucleus reticularis lateralis region.
5
In conclusion, rilmenidine exhibited in the rabbit a central hypotensive effect which originated in the same area as where clonidine acts. Specific imidazoline‐preferring receptors appear to be involved in this hypotensive effect.</description><subject>Animals</subject><subject>Antihypertensive agents</subject><subject>Antihypertensive Agents - administration & dosage</subject><subject>Antihypertensive Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Blood Pressure - drug effects</subject><subject>Brain - physiology</subject><subject>Cardiovascular system</subject><subject>Cisterna Magna</subject><subject>Dioxanes - pharmacology</subject><subject>Heart Rate - drug effects</subject><subject>Hemodynamics - drug effects</subject><subject>Idazoxan</subject><subject>Imidazoline Receptors</subject><subject>Injections</subject><subject>Injections, Intraventricular</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Oxazoles - administration & dosage</subject><subject>Oxazoles - pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Rabbits</subject><subject>Receptors, Drug - physiology</subject><subject>Rilmenidine</subject><subject>Tissue Extracts - analysis</subject><subject>Yohimbine - pharmacology</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><recordid>eNqVkcGP1CAYxYnRrOPqn2DSmLi3ViilFA9G3ayuySZ60DOh9MNhQssIne6Of710phn1tFk4QPJ-7_GRh9ArgguS1ptNQSpe54w2pCBC4GJsCWsYLe4eodVJeoxWGGOeE9I0T9GzGDcYJ5GzM3RWUoHrplyh8WqyHQwaMuNDNq4hs8Pk3QQ9DGPmTWZ726nf3tkBsgAatqMPMUEHVicoKJet91s_whDtBBkYA_pgDdalFNvN1sUQVNva8Tl6YpSL8GI5z9GPT1ffL6_zm6-fv1x-uMk1o4LmvOMNq1QJpcJVVdJOQYeFooaDYa1SVdplV2uiOVW4NFg3tWaaEUqhNhjoOXp3zN3u2h66ZVq5DbZXYS-9svJ_ZbBr-dNPkgjCG1ylgIslIPhfO4ij7G3U4JwawO-i5EIwXlf8XpAwLhitRQLfHkEdfIwBzGkaguVcrtzIuUE5NyjncuVSrrxL5pf__udkXdpM-utFV1ErZ4IatI1_XxCUY07rxL0_crfWwf4BE8iP364PV_oHFa_Fyg</recordid><startdate>199007</startdate><enddate>199007</enddate><creator>Feldman, J.</creator><creator>Tibiriça, E.</creator><creator>Bricca, G.</creator><creator>Dontenwill, M.</creator><creator>Belcourt, A.</creator><creator>Bousquet, P.</creator><general>Blackwell Publishing Ltd</general><general>Nature Publishing</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>199007</creationdate><title>Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit</title><author>Feldman, J. ; Tibiriça, E. ; Bricca, G. ; Dontenwill, M. ; Belcourt, A. ; Bousquet, P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5393-7d7854a2e2a04423daed09a3f7ef5baa4a4a2d6c1c73a02f0c86c5c5133e6f0e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Animals</topic><topic>Antihypertensive agents</topic><topic>Antihypertensive Agents - administration & dosage</topic><topic>Antihypertensive Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Blood Pressure - drug effects</topic><topic>Brain - physiology</topic><topic>Cardiovascular system</topic><topic>Cisterna Magna</topic><topic>Dioxanes - pharmacology</topic><topic>Heart Rate - drug effects</topic><topic>Hemodynamics - drug effects</topic><topic>Idazoxan</topic><topic>Imidazoline Receptors</topic><topic>Injections</topic><topic>Injections, Intraventricular</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Oxazoles - administration & dosage</topic><topic>Oxazoles - pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Rabbits</topic><topic>Receptors, Drug - physiology</topic><topic>Rilmenidine</topic><topic>Tissue Extracts - analysis</topic><topic>Yohimbine - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Feldman, J.</creatorcontrib><creatorcontrib>Tibiriça, E.</creatorcontrib><creatorcontrib>Bricca, G.</creatorcontrib><creatorcontrib>Dontenwill, M.</creatorcontrib><creatorcontrib>Belcourt, A.</creatorcontrib><creatorcontrib>Bousquet, P.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Feldman, J.</au><au>Tibiriça, E.</au><au>Bricca, G.</au><au>Dontenwill, M.</au><au>Belcourt, A.</au><au>Bousquet, P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>1990-07</date><risdate>1990</risdate><volume>100</volume><issue>3</issue><spage>600</spage><epage>604</epage><pages>600-604</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><coden>BJPCBM</coden><abstract>1
Rilmenidine has recently been introduced as a new centrally‐acting antihypertensive agent. We examined its cardiovascular effects after intracerebral injection to anaesthetized rabbits. Cumulative doses of rilmenidine injected intracisternally (1 to 300 μg kg−1) led to dose‐dependent decreases in arterial blood pressure and heart rate. The effective doses of rilmenidine were lower when injected centrally than when injected intravenously.
2
Pretreatment with the same dose of yohimbine or idazoxan shifted the rilmenidine dose‐response curves for its hypotensive and bradycardic effects to the right. Idazoxan, which has an imidazoline structure, proved to be a more active antagonist than yohimbine of rilmenidine centrally‐mediated cardiovascular effects.
3
The dose‐response curve for the central hypotensive effect of rilmenidine was also shifted to the right after pretreatment with a bovine brain extract. This extract contains the endogenous ligand of the imidazoline‐preferring receptors which is not a catecholamine.
4
Rilmenidine, like clonidine, proved to be active when micro‐injected into the rabbit nucleus reticularis lateralis region.
5
In conclusion, rilmenidine exhibited in the rabbit a central hypotensive effect which originated in the same area as where clonidine acts. Specific imidazoline‐preferring receptors appear to be involved in this hypotensive effect.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>2390682</pmid><doi>10.1111/j.1476-5381.1990.tb15853.x</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-1188 |
ispartof | British journal of pharmacology, 1990-07, Vol.100 (3), p.600-604 |
issn | 0007-1188 1476-5381 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1917804 |
source | PubMed Central |
subjects | Animals Antihypertensive agents Antihypertensive Agents - administration & dosage Antihypertensive Agents - pharmacology Biological and medical sciences Blood Pressure - drug effects Brain - physiology Cardiovascular system Cisterna Magna Dioxanes - pharmacology Heart Rate - drug effects Hemodynamics - drug effects Idazoxan Imidazoline Receptors Injections Injections, Intraventricular Male Medical sciences Oxazoles - administration & dosage Oxazoles - pharmacology Pharmacology. Drug treatments Rabbits Receptors, Drug - physiology Rilmenidine Tissue Extracts - analysis Yohimbine - pharmacology |
title | Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T19%3A56%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evidence%20for%20the%20involvement%20of%20imidazoline%20receptors%20in%20the%20central%20hypotensive%20effect%20of%20rilmenidine%20in%20the%20rabbit&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Feldman,%20J.&rft.date=1990-07&rft.volume=100&rft.issue=3&rft.spage=600&rft.epage=604&rft.pages=600-604&rft.issn=0007-1188&rft.eissn=1476-5381&rft.coden=BJPCBM&rft_id=info:doi/10.1111/j.1476-5381.1990.tb15853.x&rft_dat=%3Cproquest_pubme%3E15795369%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5393-7d7854a2e2a04423daed09a3f7ef5baa4a4a2d6c1c73a02f0c86c5c5133e6f0e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=15795369&rft_id=info:pmid/2390682&rfr_iscdi=true |